dermtech 2_0 logo
Elevating dermatologic care with non-invasive skin genomics.

DermTech 2.0 is a platform technology company that provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker®. DermTech 2.0 develops and markets products, including the DermTech Melanoma Test, to facilitate the assessment of melanoma and other skin diseases, and offers DermTech Stratum, precision biomarker services for biopharmaceutical and research partners.

Dedicated to laboratory excellence and committed to quality.

Led by a dedicated team of dermatologists, dermatopathologists and experienced laboratory professionals, DermTech 2.0 is committed to quality and customer support.

Led by a dedicated team of dermatologists, dermatopathologists and experienced laboratory professionals, DermTech 2.0 is committed to quality and customer support.
Our Mission is to elevate dermatologic care through noninvasive genomic diagnostics that empower clinicians to best serve their patients.

The innovative DermTech 2.0 Lab is CLIA certified, JCO accredited, and licensed by the New York State Department of Health.

The Joint Commission
CLIA